Generic name: SUMATRIPTAN 6mg in 0.5mL
Dosage form: injection, solution
Medically reviewed on May 14, 2018.
The maximum single recommended dose of ALSUMA is 6 mg injected subcutaneously.
The maximum recommended dose that may be given in 24 hours is two doses of ALSUMA separated by at least 1 hour. Controlled clinical trials have failed to show a clear benefit with the administration of a second 6 mg dose in patients who have failed to respond to a first dose. A second 6 mg dose should only be considered if some response to a first injection was observed.
Administration Using ALSUMA
ALSUMA is only for subcutaneous use. Intramuscular or intravascular delivery must be avoided. Patients should be directed to use injection sites with an adequate skin and subcutaneous thickness to accommodate the length of the needle.
ALSUMA is for single use only. Visually inspect the medication for particulate matter and discoloration before administration. Do not use if particulates and discolorations are noted. Discard unused portions. [see Patient Counseling Information (17.8)]
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Alsuma (sumatriptan)
- Alsuma Side Effects
- During Pregnancy or Breastfeeding
- Drug Interactions
- 1 Review
- Drug class: antimigraine agents
- FDA Alerts (1)